RBC
RXRX icon

Roble Belko & Company’s Recursion Pharmaceuticals RXRX Stock Holding History

Roble Belko & Company’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$1K Hold
141
– – ﹤0.01% 390
2025
Q1 		$1K Hold
141
– – ﹤0.01% 376
2024
Q4 		$1K Buy
141
+125
+781% +$887 ﹤0.01% 352
2024
Q3 		$0 Buy
+16
New – ﹤0.01% 393